Overview
Yongwen Li practices in Tianjin, China. Li is highly rated in 4 conditions, according to our data. Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 74 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaLi isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerLi isDistinguished. Learn about Lung Cancer.
- Advanced
- EGFR Positive Lung Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Cerebral HypoxiaLi isExperienced. Learn about Cerebral Hypoxia.
- Lung MetastasesLi isExperienced. Learn about Lung Metastases.
- NecrosisLi isExperienced. Learn about Necrosis.
- Neuroendocrine TumorLi isExperienced. Learn about Neuroendocrine Tumor.
- Neuromyelitis OpticaLi isExperienced. Learn about Neuromyelitis Optica.
- Optic NeuritisLi isExperienced. Learn about Optic Neuritis.